Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Oncology Research|January 1, 1996
Lisofylline as a modifier of radiation therapyJ S Wong, G Ara, S R Keyes, et al.International Journal of Cancer|March 28, 1997
Reversal of in vivo drug resistance by the transforming growth factor-beta inhibitor decorinB A Teicher, Y Maehara, Y Kakeji, et al.Advances in Enzyme Regulation|January 1, 1985
Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin CS R Keyes, D C Heimbrook, P M Fracasso, et al.The Journal of Cell Biology|June 1, 1976
Hepatic organelle interaction. IV. Mechanism of succinate enhancement of formaldehyde accumulation from endoplasmic reticulum N-dealkylationsH Denk, P W Moldeus, R A Schulz, et al.Cancer Research|December 1, 1984
Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1S R Keyes, P M Fracasso, D C Heimbrook, et al.Advances in Enzyme Regulation|January 1, 1995
Preferential kill of hypoxic EMT6 mammary tumor cells by the bioreductive alkylating agent porfiromycinA C Sartorelli, M F Belcourt, W F Hodnick, et al.Cancer Communications|July 1, 1991
Isolation, identification, and assay of [3H]-porfiromycin adducts of EMT6 mouse mammary tumor cell DNA: effects of hypoxia and dicumarol on adduct patternsM Tomasz, C S Hughes, D Chowdary, et al.Cancer Communications|June 1, 1991
Activity of C-7 substituted cyclic acetal derivatives of mitomycin C and porfiromycin against hypoxic and oxygenated EMT6 carcinoma cells in vitro and in vivoS Rockwell, S R Keyes, R Loomis, et al.Pageof 3